Stock listing
NASDAQ:YMAB Y mAbs Therapeutics Stock
Follow Y mAbs Therapeutics into a list and get an email when it puts out news.
Last close · NASDAQ:YMAB
$8.61 USD
Close on Sep 16, 2025 · No longer trades
- Lowest – highest close
- $2.83 – $54.26 USDSince Sep 21, 2018 · lowest Mar 22, 2023 · highest Dec 17, 2020
Delisted NASDAQ:YMAB no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:YMAB
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Y mAbs Therapeutics on 6ix
- Calls
- 17 calls with a replay · 17 with a transcript · latest Aug 8, 2025
- Decks
- 8 decks · latest May 28, 2025
Events
| Call | When | Status |
|---|---|---|
| Y mAbs Therapeutics (YMAB) Q2 2025 Earnings Call | Fri, Aug 08, 2025 · 8:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q1 2025 Earnings Call | Tue, May 13, 2025 · 8:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q4 2024 Earnings Call | Tue, Mar 04, 2025 · 8:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q3 2024 Earnings Call | Fri, Nov 08, 2024 · 8:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q2 2024 Earnings Call | Mon, Aug 12, 2024 · 8:30 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q1 2024 Earnings Call | Wed, May 08, 2024 · 8:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q4 2023 Earnings Call | Fri, Mar 01, 2024 · 8:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q3 2023 Earnings Call | Tue, Nov 14, 2023 · 9:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q2 2023 Earnings Call | Fri, Aug 11, 2023 · 9:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q1 2023 Earnings Call | Tue, May 09, 2023 · 9:00 AM ET | Replay |
All 17 calls
| Call | When | Status |
|---|---|---|
| Y mAbs Therapeutics (YMAB) Q4 2022 Earnings Call | Fri, Mar 31, 2023 · 9:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 4:00 PM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q2 2022 Earnings Call | Tue, Aug 09, 2022 · 9:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q1 2022 Earnings Call | Tue, May 10, 2022 · 9:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q4 2021 Earnings Call | Fri, Feb 25, 2022 · 9:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q3 2021 Earnings Call | Fri, Nov 05, 2021 · 9:00 AM ET | Replay |
| Y mAbs Therapeutics (YMAB) Q1 2021 Earnings Call | Fri, May 07, 2021 · 9:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (May 2025) | Technical | 49 slides | May 28, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 17 slides | May 13, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 21 slides | Mar 4, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 20 slides | Nov 8, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 20 slides | Aug 12, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 20 slides | May 8, 2024 |
| Q4 2023 Earnings Presentation | Earnings | 21 slides | Mar 1, 2024 |
| Corporate Update (January 2024) | Corporate update | 25 slides | Jan 9, 2024 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Healy Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); BioAge Labs, Inc. (Director · Since at least Sep 25, 2024); Rapport Therapeutics, Inc. (Director · Since at least Jun 6, 2024); ArriVent BioPharma, Inc. (Director · Since at least Jan 25, 2024); CinCor Pharma Inc (Director · Jan 6, 2022 – Nov 28, 2022 · Past); Bolt Biotherapeutics, Inc. (Director · Feb 4, 2021 – Jun 12, 2024 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Mar 18, 2024 · Past); Coherus Oncology, Inc. (Director · May 22, 2019 – Jan 7, 2022 · Past); Natera, Inc. (Director · Sep 14, 2018 – Apr 25, 2025 · Past) | Director · Since at least Jun 12, 2019 |
| David Gill Other companies: Telix Pharmaceuticals Limited (Chair & Independent Non-Executive Director · Since at least May 11, 2026); Evolus, Inc. Common Stock (Director · Since at least Feb 12, 2018); Strongbridge Biopharma plc (Director · Sep 3, 2019 – Oct 5, 2021 · Past); STRATA Skin Sciences, Inc. (Director · May 30, 2018 – Nov 22, 2019 · Past); Melinta Therapeutics Inc (Director · May 25, 2018 – Jun 11, 2019 · Past); Ocugen, Inc. (Director · Dec 9, 2016 – Jun 15, 2018 · Past); Cempra Inc (Director · Jan 1, 2016 – Jan 3, 2017 · Past); EndoChoice Holdings Inc (President and CFO · Aug 14, 2015 – Nov 22, 2016 · Past) | Director · Since at least Sep 20, 2018 |
| Peter P Pfreundschuh Other companies: Voyager Therapeutics, Inc. (Chief Financial Officer · Sep 19, 2022 – Feb 21, 2024 · Past); Korro Bio, Inc. (Chief Financial Officer · Dec 1, 2020 – Feb 18, 2022 · Past); UroGen Pharma Ltd. (Chief Financial Officer · Jan 1, 2019 – Oct 15, 2020 · Past); Sucampo Pharmaceuticals Inc (CFO · Mar 20, 2017 – Feb 13, 2018 · Past); Immunomedics Inc (Chief Financial Officer · Aug 20, 2015 – Aug 20, 2015 · Past) | EVP, CFO and Treasurer · Since at least Jun 28, 2024 |
| Gérard Ber Other companies: Lantheus Holdings, Inc. (Director · Since at least May 6, 2022) | Director · Jul 15, 2022 – Jun 10, 2024 · Past |
| Michael J Rossi Other companies: Mirion Technologies, Inc. (Medical Group President · Nov 1, 2023 – Nov 1, 2023 · Past) | PRESIDENT & CEO, Director · Since at least Nov 6, 2023 |
| Biotech ApS WG | Director · Since at least May 15, 2023 |
| Douglas J Gentilcore | SVP, Danyelza Bus. Unit Head · Since at least Sep 16, 2025 |
| Johan Wedell-Wedellsborg | Director · Since at least Sep 20, 2018 |
| John LaRocca | SVP, General Counsel & Secry · Since at least Sep 16, 2025 |
| Pedro Claus Juan Moller-San | Director and CEO, Director · Sep 20, 2018 – Dec 14, 2021 · Past |
All 15 people
| Person | Seat |
|---|---|
| Philip Karl Herman | SVP & CCO · Jan 1, 2020 – Dec 15, 2020 · Past |
| Steen Lisby | SVP & CHIEF SCIENTIFIC OFFICER · Jan 18, 2024 – Jan 18, 2024 · Past |
| Susan Laura Smith | SVP & CHIEF COMMERCIAL OFFICER · Dec 14, 2021 – Mar 5, 2024 · Past |
| Torben Lund-Hansen | SVP & CHIEF TECHNICAL OFFICER · Apr 26, 2022 – Aug 28, 2024 · Past |
| Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER · Jun 2, 2020 – Mar 5, 2024 · Past |
Log in to ask 6ix AI your own questions about Y mAbs Therapeutics.